TY  - JOUR
TI  - Long-term outcomes of COVID-19 infection in patients with solid tumors
AB  - Objectives:  We analyzed the impact of some clinical and disease-specific factors on the longterm outcomes of SARS-CoV-2 infection in patients with solid tumors.   Methods:  Total of 739 patients with known solid malignancy and infected by SARS-CoV-2 before the beginning of vaccination were examined.  Results: Seventy-six cancer patients died from COVID-19 infection-related effects such as mostly pulmonary and cardiovascular system disorders after a median 16-month follow-up (67.1% and 14.5%; respectively). Compared with survivors (n = 468), non-survivors due to COVID-19 infection related effects (n = 76) were more likely to be aged ≥ 65 years and diagnosis with lung cancer (p = 0.01). Also, female patients were at decreased risk of mortality [OR: 0.34 (95% CI: 0.18-0.65)]. Furthermore, patients with tumor stage IV, active/stable/progressive disease and patients receiving active anticancer therapy were at increased risk of mortality (p = 0.01).  Conclusions:  The patients with aged ≥ 65 years, diagnosed with lung cancer, receiving active anticancer therapy, with active/stable/progressive and advanced cancer stage were at increased risk of mortality from COVID-19 infection in long-term follow-up.
AU  - Ünsal, Oktay
AU  - YAZICI, Ozan
AU  - özkan, ömer faruk
AU  - tahtaci, gozde
AU  - Ozdemir, Nuriye
AU  - Üner, Aytuğ
AU  - GÜNEL, NAZAN
AU  - Ozet, Ahmet
DO  - 10.18621/eurj.1251443
PY  - 2023
JO  - The European Research Journal
VL  - 9
IS  - 5
SN  - 2149-3189
SP  - 932
EP  - 939
DB  - TRDizin
UR  - http://search/yayin/detay/1194862
ER  -